期刊
STEM CELLS AND DEVELOPMENT
卷 14, 期 4, 页码 384-394出版社
MARY ANN LIEBERT, INC
DOI: 10.1089/scd.2005.14.384
关键词
-
Sanfilippo syndrome type B is caused by alpha- N- acetylglucosaminidase ( Naglu) enzyme deficiency leading to an accumulation of undegraded heparan sulfate, a glycosaminoglycan ( GAG). Cell therapy is a promising new treatment and human umbilical cord blood ( hUCB) cell transplantation may be preferred for delivery of the missing enzyme. We investigated the ability of mononuclear hUCB cells administered into the lateral cerebral ventricle to ameliorate/ prevent histopathological changes in mice modeling Sanfilippo syndrome type B. These are the first results supporting enzyme replacement by administered hUCB cells. In vivo, transplanted hUCB cells survived long- term ( 7 months), migrated into the parenchyma of the brain and peripheral organs, expressed neural antigens, and exhibited neuron and astrocyte- like morphology. Transplant benefits were also demonstrated by stable cytoarchitecture in the hippocampus and cerebellum, and by reduced GAGs in the livers of treated mutant mice. A hUCB cell transplant may be an effective therapeutic strategy for enzyme delivery in Sanfilippo syndrome type B.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据